혈소판 유래 성장인자(PDGFs) 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향 및 예측(2020-2034년)
Platelet-derived Growth Factors Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2020-2034
상품코드:1508448
리서치사:Transparency Market Research
발행일:2024년 05월
페이지 정보:영문 213 Pages
라이선스 & 가격 (부가세 별도)
한글목차
혈소판 유래 성장인자(PDGFs) 시장 - 조사 범위
TMR의 조사 보고서 "세계의 혈소판 유래 성장인자(PDGFs) 시장"은 2024년부터 2034년까지 예측 기간 동안 시장 지표에 대한 귀중한 통찰력을 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회를 조사했습니다. 이 보고서는 2024년을 기준연도로, 2034년을 예측 연도로 하여 2018년부터 2034년까지 세계 혈소판 유래 성장인자(PDGFs) 시장의 수익과 예측을 제공합니다. 또한 2024년부터 2034년까지 세계 혈소판 유래 성장인자(PDGFs) 시장의 연평균 복합 성장률(CAGR%)을 제시합니다.
이 보고서는 광범위한 1차 조사와 KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 대상으로 한 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도 자료, 관련 문서 등을 참고하여 혈소판 유래 성장인자(PDGFs) 시장을 추론하기 위한 2차 조사를 통해 작성되었습니다.
시장 현황
2023년 시장 규모
2억 2,870만 달러
2034년 시장 규모
4억 7,800만 달러
CAGR
7%
이 보고서는 세계 혈소판 유래 성장인자(PDGFs) 시장의 경쟁 환경을 조사했습니다. 세계 혈소판 유래 성장인자(PDGFs) 시장에서 활동하는 주요 기업들이 확인되었으며, 각 기업들은 다양한 속성으로 프로파일링되었습니다. 기업 개요, 재무 상태, 최근 동향, SWOT는 이 보고서에서 다루는 세계 혈소판 유래 성장인자(PDGFs) 시장 기업의 속성입니다.
목차
제1장 서문
제2장 전제조건과 조사 방법
제3장 주요 요약
제4장 시장 개요
서론
개요
시장 역학
제5장 주요 인사이트
가격 분석
국가/지역별 규제 시나리오
질병의 만연 - 세계 규모
COVID-19의 산업에 대한 영향 분석
제6장 세계 시장 분석과 예측 : 유형별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 유형별, 2020-2034년
PDGF-AA
PDGF-BB
PDGF-CC
PDGF-DD
PDGF-AB
시장의 매력 분석 : 유형별
제7장 세계 시장 분석과 예측 : 용도별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 용도별, 2020-2034년
정형외과
심장수술
창상치유
암 치료
기타
시장의 매력 분석 : 용도별
제8장 세계 시장 분석과 예측 : 최종사용자별
서론과 정의
주요 조사 결과와 발전
시장 매출 예측 : 최종사용자별, 2020-2034년
병원
클리닉
기타
시장의 매력 분석 : 최종사용자별
제9장 세계 시장 분석과 예측 : 지역별
주요 조사 결과
시장 매출 예측 : 지역별, 2020-2034년
북미
유럽
아시아태평양
라틴아메리카
중동 및 아프리카
시장의 매력 분석 : 지역별
제10장 북미 시장 분석과 예측
제11장 유럽 시장 분석과 예측
제12장 아시아태평양 시장 분석과 예측
제13장 라틴아메리카 시장 분석과 예측
제14장 중동 및 아프리카 시장 분석과 예측
제15장 경쟁 구도
시장 기업 - 경쟁 매트릭스(기업 Tier 및 규모별)
시장 점유율 분석 기업별(2023년)
기업 개요
Thermo Fisher Scientific Inc.(PeproTech, Inc.)
Stryker
Sigma-Aldrich(Merck KGaA)
OriGene Technologies
iXCells Biotechnologies
Abbexa Ltd.
Bio-Techne
STEMCELL Technologies
Neuromics
GenScript Biotech Corporation
LSH
영문 목차
영문목차
Platelet-derived Growth Factors (PDGFs) Market - Scope of Report
TMR's report on the global platelet-derived growth factors (PDGFs) market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global platelet-derived growth factors (PDGFs) market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global platelet-derived growth factors (PDGFs) market from 2024 to 2034.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the platelet-derived growth factors (PDGFs) market.
Market Snapshot
Market Value in 2023
US$ 228.7 Mn
Market Value in 2034
US$ 478 Mn
CAGR
7%
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global platelet-derived growth factors (PDGFs) market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global platelet-derived growth factors (PDGFs) market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global platelet-derived growth factors (PDGFs) market.
The report delves into the competitive landscape of the global platelet-derived growth factors (PDGFs) market. Key players operating in the global platelet-derived growth factors (PDGFs) market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global platelet-derived growth factors (PDGFs) market profiled in this report.
Key Questions Answered in Global platelet-derived growth factors (PDGFs) Market Report:
What is the sales/revenue generated by platelet-derived growth factors (PDGFs) across all regions during the forecast period?
What are the opportunities in the global platelet-derived growth factors (PDGFs) market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?
Platelet-derived Growth Factors (PDGFs) Market - Research Objectives and Research Approach
The comprehensive report on the global platelet-derived growth factors (PDGFs) market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
The report analyzes the global platelet-derived growth factors (PDGFs) market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global platelet-derived growth factors (PDGFs) market.
Table of Contents
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Platelet-derived Growth Factors (PDGFs) Market
4. Market Overview
4.1. Introduction
4.1.1. Segment Definition
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
5. Key Insights
5.1. Pricing Analysis
5.2. Regulatory Scenario by Country/Region
5.3. Prevalence of Diseases- Globally
5.4. COVID 19 Impact Analysis on Industry
6. Global Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast, by Type
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Type, 2020-2034
6.3.1. PDGF-AA
6.3.2. PDGF-BB
6.3.3. PDGF-CC
6.3.4. PDGF-DD
6.3.5. PDGF-AB
6.4. Market Attractiveness Analysis, by Type
7. Global Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast, by Application
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Application, 2020-2034
7.3.1. Orthopedic Surgery
7.3.2. Cardiac Surgery
7.3.3. Wound Healing
7.3.4. Cancer Treatment
7.3.5. Others
7.4. Market Attractiveness Analysis, by Application
8. Global Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast, by End-user
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by End-user, 2020-2034
8.3.1. Hospitals
8.3.2. Clinics
8.3.3. Others
8.4. Market Attractiveness Analysis, by End-user
9. Global Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2020-2034
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Type, 2020-2034
10.2.1. PDGF-AA
10.2.2. PDGF-BB
10.2.3. PDGF-CC
10.2.4. PDGF-DD
10.2.5. PDGF-AB
10.3. Market Value Forecast, by Application, 2020-2034
10.3.1. Orthopedic Surgery
10.3.2. Cardiac Surgery
10.3.3. Wound Healing
10.3.4. Cancer Treatment
10.3.5. Others
10.4. Market Value Forecast, by End-user, 2020-2034
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Others
10.5. Market Value Forecast, by Country, 2020-2034
10.5.1. U.S.
10.5.2. Canada
10.6. Market Attractiveness Analysis
10.6.1. By Type
10.6.2. By Application
10.6.3. By End-user
10.6.4. By Country
11. Europe Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Type, 2020-2034
11.2.1. PDGF-AA
11.2.2. PDGF-BB
11.2.3. PDGF-CC
11.2.4. PDGF-DD
11.2.5. PDGF-AB
11.3. Market Value Forecast, by Application, 2020-2034
11.3.1. Orthopedic Surgery
11.3.2. Cardiac Surgery
11.3.3. Wound Healing
11.3.4. Cancer Treatment
11.3.5. Others
11.4. Market Value Forecast, by End-user, 2020-2034
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Others
11.5. Market Value Forecast, by Country/Sub-region, 2020-2034
11.5.1. Germany
11.5.2. UK
11.5.3. France
11.5.4. Italy
11.5.5. Spain
11.5.6. Rest of Europe
11.6. Market Attractiveness Analysis
11.6.1. By Type
11.6.2. By Application
11.6.3. By End-user
11.6.4. By Country/Sub-region
12. Asia Pacific Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Type, 2020-2034
12.2.1. PDGF-AA
12.2.2. PDGF-BB
12.2.3. PDGF-CC
12.2.4. PDGF-DD
12.2.5. PDGF-AB
12.3. Market Value Forecast, by Application, 2020-2034
12.3.1. Orthopedic Surgery
12.3.2. Cardiac Surgery
12.3.3. Wound Healing
12.3.4. Cancer Treatment
12.3.5. Others
12.4. Market Value Forecast, by End-user, 2020-2034
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Others
12.5. Market Value Forecast, by Country/Sub-region, 2020-2034
12.5.1. China
12.5.2. Japan
12.5.3. India
12.5.4. Australia & New Zealand
12.5.5. Rest of Asia Pacific
12.6. Market Attractiveness Analysis
12.6.1. By Type
12.6.2. By Application
12.6.3. By End-user
12.6.4. By Country/Sub-region
13. Latin America Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Type, 2020-2034
13.2.1. PDGF-AA
13.2.2. PDGF-BB
13.2.3. PDGF-CC
13.2.4. PDGF-DD
13.2.5. PDGF-AB
13.3. Market Value Forecast, by Application, 2020-2034
13.3.1. Orthopedic Surgery
13.3.2. Cardiac Surgery
13.3.3. Wound Healing
13.3.4. Cancer Treatment
13.3.5. Others
13.4. Market Value Forecast, by End-user, 2020-2034
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Others
13.5. Market Value Forecast, by Country/Sub-region, 2020-2034
13.5.1. Brazil
13.5.2. Mexico
13.5.3. Rest of Latin America
13.6. Market Attractiveness Analysis
13.6.1. By Type
13.6.2. By Application
13.6.3. By End-user
13.6.4. By Country/Sub-region
14. Middle East & Africa Platelet-derived Growth Factors (PDGFs) Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Type, 2020-2034
14.2.1. PDGF-AA
14.2.2. PDGF-BB
14.2.3. PDGF-CC
14.2.4. PDGF-DD
14.2.5. PDGF-AB
14.3. Market Value Forecast, by Application, 2020-2034
14.3.1. Orthopedic Surgery
14.3.2. Cardiac Surgery
14.3.3. Wound Healing
14.3.4. Cancer Treatment
14.3.5. Others
14.4. Market Value Forecast, by End-user, 2020-2034
14.4.1. Hospitals
14.4.2. Clinics
14.4.3. Others
14.5. Market Value Forecast, by Country/Sub-region, 2020-2034
14.5.1. GCC Countries
14.5.2. South Africa
14.5.3. Rest of Middle East & Africa
14.6. Market Attractiveness Analysis
14.6.1. By Type
14.6.2. By Application
14.6.3. By End-user
14.6.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competition Matrix (By Tier and Size of companies)
15.2. Market Share Analysis By Company (2023)
15.3. Company Profiles
15.3.1. Thermo Fisher Scientific Inc. (PeproTech, Inc.)
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. Financial Overview
15.3.1.4. SWOT Analysis
15.3.1.5. Strategic Overview
15.3.2. Stryker
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. Financial Overview
15.3.2.4. SWOT Analysis
15.3.2.5. Strategic Overview
15.3.3. Sigma-Aldrich(Merck KGaA)
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. Financial Overview
15.3.3.4. SWOT Analysis
15.3.3.5. Strategic Overview
15.3.4. OriGene Technologies
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. Financial Overview
15.3.4.4. SWOT Analysis
15.3.4.5. Strategic Overview
15.3.5. iXCells Biotechnologies
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. Financial Overview
15.3.5.4. SWOT Analysis
15.3.5.5. Strategic Overview
15.3.6. Abbexa Ltd.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. Financial Overview
15.3.6.4. SWOT Analysis
15.3.6.5. Strategic Overview
15.3.7. Bio-Techne
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. Financial Overview
15.3.7.4. SWOT Analysis
15.3.7.5. Strategic Overview
15.3.8. STEMCELL Technologies
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. Financial Overview
15.3.8.4. SWOT Analysis
15.3.8.5. Strategic Overview
15.3.9. Neuromics
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. Financial Overview
15.3.9.4. SWOT Analysis
15.3.9.5. Strategic Overview
15.3.10. GenScript Biotech Corporation
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
